Xylem (NYSE:XYL) Issues Earnings Results, Beats Expectations By $0.12 EPS

Xylem (NYSE:XYL) issued its earnings results on Tuesday. The industrial products company reported $1.46 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.12, Zacks reports. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The company had revenue of $2.34 billion for the quarter, compared to analyst estimates of $2.34 billion. Xylem updated its FY 2026 guidance to 5.550-5.700 EPS.

Xylem Trading Up 0.4%

Xylem stock opened at $120.20 on Tuesday. The stock has a 50-day moving average price of $114.27 and a 200 day moving average price of $122.55. Xylem has a 52 week low of $105.29 and a 52 week high of $154.27. The stock has a market cap of $28.57 billion, a PE ratio of 29.90, a P/E/G ratio of 1.70 and a beta of 1.03. The company has a current ratio of 1.46, a quick ratio of 1.10 and a debt-to-equity ratio of 0.13.

Xylem Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were given a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date was Thursday, May 28th. Xylem’s dividend payout ratio (DPR) is currently 42.79%.

Analyst Upgrades and Downgrades

XYL has been the topic of several research analyst reports. Stifel Nicolaus decreased their price target on Xylem from $159.00 to $157.00 and set a “buy” rating on the stock in a research note on Monday, July 20th. JPMorgan Chase & Co. dropped their price objective on Xylem from $170.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, April 16th. Oppenheimer reduced their price objective on Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a report on Wednesday, April 29th. Weiss Ratings downgraded Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research report on Friday, May 8th. Finally, Barclays lowered their target price on Xylem from $156.00 to $154.00 and set an “overweight” rating on the stock in a report on Wednesday, April 29th. Eight investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $153.15.

Insider Transactions at Xylem

In other news, CAO Geri-Michelle Mcshane sold 4,269 shares of Xylem stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the sale, the chief accounting officer directly owned 3,605 shares in the company, valued at $423,443.30. The trade was a 54.22% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Jerome A. Peribere acquired 1,210 shares of the business’s stock in a transaction dated Monday, May 4th. The stock was purchased at an average cost of $116.61 per share, with a total value of $141,098.10. Following the transaction, the director owned 27,209 shares of the company’s stock, valued at approximately $3,172,841.49. The trade was a 4.65% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.32% of the stock is currently owned by corporate insiders.

Institutional Trading of Xylem

A number of hedge funds have recently bought and sold shares of XYL. Wexford Capital LP acquired a new position in Xylem in the 3rd quarter valued at $27,000. FWL Investment Management LLC acquired a new stake in shares of Xylem during the second quarter worth $43,000. DV Equities LLC acquired a new stake in shares of Xylem during the fourth quarter worth $46,000. Johnson Financial Group Inc. purchased a new stake in shares of Xylem in the third quarter valued at $77,000. Finally, Zions Bancorporation National Association UT increased its stake in Xylem by 36.1% in the fourth quarter. Zions Bancorporation National Association UT now owns 679 shares of the industrial products company’s stock valued at $92,000 after purchasing an additional 180 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.